WO2007132439A1 - Composition de deodorant a action prolongee - Google Patents

Composition de deodorant a action prolongee Download PDF

Info

Publication number
WO2007132439A1
WO2007132439A1 PCT/IL2006/000566 IL2006000566W WO2007132439A1 WO 2007132439 A1 WO2007132439 A1 WO 2007132439A1 IL 2006000566 W IL2006000566 W IL 2006000566W WO 2007132439 A1 WO2007132439 A1 WO 2007132439A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
deodorant
urea
long lasting
formulation
Prior art date
Application number
PCT/IL2006/000566
Other languages
English (en)
Inventor
Philip Hlavin
Original Assignee
Hlavin Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hlavin Industries Ltd. filed Critical Hlavin Industries Ltd.
Priority to PCT/IL2006/000566 priority Critical patent/WO2007132439A1/fr
Priority to JP2006156434A priority patent/JP2006335761A/ja
Publication of WO2007132439A1 publication Critical patent/WO2007132439A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0229—Sticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A61K2800/874—Roll-on

Definitions

  • the present invention relates to compositions and in particular to deodorant formulations having long term effectiveness.
  • Deodorant compositions typically are provided in a deodorant spray, as a cream or roll on dry liquid or within a waxy stick, and these are effective to a greater or lesser extent, but mostly have an effect lasting less than a number of hours, and typically no more than 24 hours and often considerably less.
  • WO0024370 describes dermatologic gels for the treatment of acne vulgaris and herpes simplex containing methenamine. No reference is made to using this material in deodorants however.
  • WO02074279A2 describes a formulation for treating body odor, in particular foot odor.
  • the formulation comprises a combination of hexamine and zinc oxide or pharmaceutically acceptable salts thereof.
  • the formulation is preferably an aqueous formulation, but it may be a powder formulation.
  • Other ingredients of preferred compositions thereof include glycerol and talc.
  • polyhexamethylene biguanide Another known antimicrobial agent is polyhexamethylene biguanide.
  • US Patent Application No.2004008295 describes a medical dressing useful in healing of wounds including polyhexamethylene biguanide as an antimicrobial agent.
  • EPl 216691 describes an antibacterial composition comprising a synergistic mixture of a fragrance aldehyde and a preservative.
  • One composition discussed, and having antibacterial effect includes polyaminopropyl biguanide.
  • US 6,010,687 discloses a deodorant composition for topical application to human skin which is characterized in that it comprises an effective amount of polyhexamethylene biguanide and an effective amount of chlorhexidine in a cosmetically acceptable carrier.
  • IL Patent Application No.164640 by the present applicant claims a long lasting deodorant composition comprising a synergistic combination of polyaminopropyl biguanide and methenamine.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a cream.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a stick.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a roll-on.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a spray.
  • a further object of the invention is to provide a deodorant composition that gives odor free protection for 4 to 7 days.
  • deodorant formulations containing urea, imidazolidinyl urea, or the salts of ethylenediaminetetraacedic acid (EDTA), particularly the tetrasodiun salt have long lasting deodorant effects especially when used together with ethylhexylglycerin and/or O-cymen-5-ol.
  • EDTA ethylenediaminetetraacedic acid
  • deodorant compositions of the present invention are readily detectable by comparing the odor of an untreated armpit to a treated armpit of the same subject.
  • Ethylhexylglycerin is known to have deodorant properties. But these are short lived, less than 24 hours. When, however, urea and/or EDTA tetrasodium salt is added to a formulation containing ethylhexylglycerin the deodorant protection is extended to between 5-7 days.
  • a long lasting deodorant composition comprising a deodorant base formulation and between 0.1% and 30% of either urea, imidazolidinyl urea or EDTA salt, or any mixture of them.
  • composition there is included l%-8% ethylhexylglycerin.
  • Another preferred composition includes 0.01% to 5% O-Cymen-5-ol.
  • the deodorant composition comprises between 0.3% to 10% urea or imidazolidinyl urea and /or EDTA salt.
  • a most preferred formulation contains 0.1% to 5% urea or imidazolidinyl urea and 0.1% to 5% EDTA salt and 0.05% to 0.5% O-Cymen-5-ol.
  • a most preferred formulation contains 0.1% to 5% urea or imidazolidinyl urea and/or 0.1% to 5% EDTA salt
  • the O-Cymen-5-ol can have a concentration of 0.05% to 0.5%, and preferably between 0.03% to 1%..
  • composition of this invention may be applied to the armpit and gives a long lasting deodorant effect for up to 5 to 7 days.
  • the deodorant formulation comprises about 1% urea or imidazoli dinyl urea and /or 1% tetrasodium EDTA .
  • the deodorant composition can be formulated in any of the conventional form, such as a cream, a stick, a roll-on or spray.
  • the base deodorant formulations can of course vary, and may include natural creams and oils, fragrances, humectants and powders such as Talc, starch, zinc oxide, as long as the cosmetic cream base is compatible with the active ingredients.
  • Some of the ingredients that we found satisfactory for deodorant formulations are petrolatum, talc, Zinc oxide, potato starch, rice starch, triethyl citrate, chamomile oil, arnica oil, calendula oil, BHT, chlorphenesin, propylene glycol, sodium stearate, ethylhexylgrycerin, cremofor, panthenol, hydroxyethyl cellulose, O-Cymen-5-ol and fragrance.
  • Example 1 Long lasting deodorant cream
  • Example 1 The formulation of Example 1 was tested on 10 people and gave deodorant protection of from 5-7 days whereas without the tetrasodiun EDTA, protection lasted for less than 24 hours.
  • Example 2 The formulation of Example 2 was tested on 10 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
  • Example 3 The formulation of Example 3 was tested on 11 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
  • Example 4 The formulation of Example 4 was tested on 11 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
  • Example 5 The formulation of Example 5 was tested on 10 people and gave deodorant protection of from 5-7 days whereas a control gave protection that lasted less than 24 hours.
  • Example 6 The formulation of Example 6 was tested on 9 people and gave deodorant protection of from 4-7 days whereas a control group had protection that lasted for less than 24 hours, and with either imidazolidinyl urea or tetrasodiun EDTA alone protection lasted 2-3 days.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition de déodorant à action prolongée comprenant une formulation de base acceptable sur le plan cosmétique renfermant entre 0,1 % et 30 % d'un composé sélectionné parmi l'urée, l'urée imidazolidinyle ou un sel EDTA acceptable sur le plan cosmétique.
PCT/IL2006/000566 2005-06-05 2006-05-14 Composition de deodorant a action prolongee WO2007132439A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IL2006/000566 WO2007132439A1 (fr) 2006-05-14 2006-05-14 Composition de deodorant a action prolongee
JP2006156434A JP2006335761A (ja) 2005-06-05 2006-06-05 長期間作用する脱臭組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2006/000566 WO2007132439A1 (fr) 2006-05-14 2006-05-14 Composition de deodorant a action prolongee

Publications (1)

Publication Number Publication Date
WO2007132439A1 true WO2007132439A1 (fr) 2007-11-22

Family

ID=36754299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2006/000566 WO2007132439A1 (fr) 2005-06-05 2006-05-14 Composition de deodorant a action prolongee

Country Status (1)

Country Link
WO (1) WO2007132439A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216174A1 (fr) * 2016-06-17 2017-12-21 Unilever Plc Produits déodorants
WO2018036625A1 (fr) * 2016-08-20 2018-03-01 Symrise Ag Mélange conservateur

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069896A (en) * 1989-06-01 1991-12-03 The Gillette Company Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
US5162378A (en) * 1990-04-20 1992-11-10 Revlon Consumer Products Corporation Silicone containing water-in-oil microemulsions having increased salt content
JPH11253542A (ja) * 1998-03-10 1999-09-21 Earth Chem Corp Ltd 脱臭効力増強剤およびこれを用いた脱臭剤
US20010043911A1 (en) * 2000-03-31 2001-11-22 Kao Corporation Deodorant composition
WO2002047642A1 (fr) * 2000-12-15 2002-06-20 Schering Ag Preparations de soin pour la peau, hypoallergeniques et non irritantes
WO2002072018A2 (fr) * 2001-03-09 2002-09-19 R.F. Technology Consultants, Inc. Composition dermatologique en creme / poudre
US6468512B1 (en) * 2000-11-22 2002-10-22 Avon Products, Inc. Gel compositions
US20030152644A1 (en) * 2001-10-23 2003-08-14 Shanta Modak Gentle-acting skin-disinfectants
US20050089488A1 (en) * 2003-10-27 2005-04-28 Kim Joo W. Deodorant composition with monocyclic, unsaturated sequiterpene alcohols and glyceryl monoalkyl ethers as synergistic active deodorant agents

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069896A (en) * 1989-06-01 1991-12-03 The Gillette Company Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
US5162378A (en) * 1990-04-20 1992-11-10 Revlon Consumer Products Corporation Silicone containing water-in-oil microemulsions having increased salt content
JPH11253542A (ja) * 1998-03-10 1999-09-21 Earth Chem Corp Ltd 脱臭効力増強剤およびこれを用いた脱臭剤
US20010043911A1 (en) * 2000-03-31 2001-11-22 Kao Corporation Deodorant composition
US6468512B1 (en) * 2000-11-22 2002-10-22 Avon Products, Inc. Gel compositions
WO2002047642A1 (fr) * 2000-12-15 2002-06-20 Schering Ag Preparations de soin pour la peau, hypoallergeniques et non irritantes
WO2002072018A2 (fr) * 2001-03-09 2002-09-19 R.F. Technology Consultants, Inc. Composition dermatologique en creme / poudre
US20030152644A1 (en) * 2001-10-23 2003-08-14 Shanta Modak Gentle-acting skin-disinfectants
US20050089488A1 (en) * 2003-10-27 2005-04-28 Kim Joo W. Deodorant composition with monocyclic, unsaturated sequiterpene alcohols and glyceryl monoalkyl ethers as synergistic active deodorant agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 14 22 December 1999 (1999-12-22) *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216174A1 (fr) * 2016-06-17 2017-12-21 Unilever Plc Produits déodorants
CN109310600A (zh) * 2016-06-17 2019-02-05 荷兰联合利华有限公司 除臭产品
US20190125640A1 (en) * 2016-06-17 2019-05-02 Conopco, Inc., D/B/A Unilever Deodorant products
AU2017285148B2 (en) * 2016-06-17 2019-05-16 Unilever Global Ip Limited Deodorant products
US10722435B2 (en) 2016-06-17 2020-07-28 Conopco, Inc. Deodorant products
EA036758B1 (ru) * 2016-06-17 2020-12-17 Юнилевер Н.В. Дезодорирующие продукты
CN109310600B (zh) * 2016-06-17 2021-11-26 联合利华知识产权控股有限公司 除臭产品
WO2018036625A1 (fr) * 2016-08-20 2018-03-01 Symrise Ag Mélange conservateur
US11400035B2 (en) 2016-08-20 2022-08-02 Symrise Ag Preservative mixture

Similar Documents

Publication Publication Date Title
JP3529093B2 (ja) 殺菌活性をもった化合物の組み合わせ
US4331653A (en) Composition for a topical cream for curtailing bleeding and treating skin disorders
US4777034A (en) Compositions for counteracting the degradations and inconvenience of perspiration
JP2011513267A (ja) 活性成分の組み合わせおよびその使用
EP2934121B1 (fr) Compositions antimicrobiennes améliorées
WO2019086327A1 (fr) Utilisation de niacinamide équilibrer le microbiome
JP2007016045A (ja) ローズマリー抽出物およびｄｈａを含有する化粧品組成物
US6426061B1 (en) Method and composition for preventing sweat-related odor
JP2007145771A (ja) 殺菌剤組成物及びデオドラント剤
WO2009007089A2 (fr) Utilisation de diols vicinaux à chaîne courte comme moyens antitranspirants
JP3908244B2 (ja) 男性臭生成抑制デオドラント剤
KR20060020630A (ko) 피지 관련 피부 질환의 국소 치료방법
EP2385818B1 (fr) Diols utilisés comme agents antitranspirants
WO2007132439A1 (fr) Composition de deodorant a action prolongee
JPH06509081A (ja) 粉末状体臭除去組成物
JP4743704B2 (ja) 腋臭菌用抗菌剤、並びに該抗菌剤を含有する腋臭防止剤及び皮膚外用剤
US10596092B2 (en) Deodorant composition and a method for preparing thereof
JP2007145750A (ja) 腋臭菌用抗菌剤、並びに該抗菌剤を含有する腋臭防止剤及び皮膚外用剤
EP3226827B2 (fr) Compositions anti-transpirantes/déodorantes sans aluminium et procédé pour les préparer
JP2006335761A (ja) 長期間作用する脱臭組成物
WO2021219763A1 (fr) Liquide ionique en tant qu'anti-transpirant
JP4293883B2 (ja) デオドラント組成物
EP3374032A1 (fr) Composition antitranspirante
JP4831960B2 (ja) 頭皮頭髪用組成物
JPS63174920A (ja) 防臭剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06728349

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06728349

Country of ref document: EP

Kind code of ref document: A1